Our study's goal was to evaluate the usage of epinephrine in ED patients who
experienced anaphylaxis. Evaluate the route of administration (intravenous,
intramuscular, subcutaneous); determine whether epinephrine was used as an
initial treatment to manage anaphylaxis; and determine whether there is a
correlation between the dose used and the frequency of cardiovascular adverse
events. The Preferred Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) guideline was followed in the conduct of this investigation.
We located publications that addressed the use of epinephrine to treat ANA in
the ED by searching PubMed, Scopus, and the Web of Science Core Collection. A
language limitation was applied in order to include articles published in English.
The publication date limitation was applied only to articles published between
2010 and 2024. To minimize the risk of missing any pertinent citations, we also
thoroughly reviewed the reference lists of the original papers included. We found
that the risk of overdosing and serious cardiovascular events is significantly
increased when administering an intravenous adrenaline bolus. The results of
this study supported the safety of intramuscular epinephrine and the need for
more awareness and further instruction on IV bolus epinephrine in ANA
patients. In order to manage anaphylactic responses, it is recommended that
emergency department staff undergo educational training on proper epinephrine
administration.
Keywords: Epinephrine, emergency department, anaphylaxis
